Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Milestone Scientific (MLSS)
NYSE MKT:MLSS
RESEARCH TOOLSreports
Holding MLSS?
Track your performance easily
MLSS Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.52 - $1.10
Previous Close$0.8
Volume419.24K
Average Volume (3M)143.06K
Market Cap
$62.09M
Enterprise Value$57.62M
Total Cash (Recent Filing)$4.78M
Total Debt (Recent Filing)$311.69K
Price to Earnings (P/E)―
Beta1.06
Next Earnings
Apr 07, 2025EPS Estimate
-$0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.06
Shares Outstanding77,892,083
10 Day Avg. Volume121,291
30 Day Avg. Volume143,064
Standard Deviation0.20
R-Squared0.08
Alpha0.00182
Financial Highlights & Ratios
Price to Book (P/B)10.28
Price to Sales (P/S)6.99
Price to Cash Flow (P/CF)-15.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue6.49
Enterprise Value/Gross Profit8.48
Enterprise Value/Ebitda-12.66
Forecast
1Y Price Target
$2.13Price Target Upside130.27% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Milestone Scientific News
PremiumCompany Announcements
Milestone Scientific Inc. Reports Q3 2024 FinancialsPremiumCompany Announcements
Milestone Scientific Announces Leadership Transition and Future Plans
Ownership Overview
22.99% Insiders
3.91% Mutual Funds
1.03% Other Institutional Investors
69.33% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
MLSS FAQ
What was Milestone Scientific’s price range in the past 12 months?
Milestone Scientific lowest stock price was $0.52 and its highest was $1.10 in the past 12 months.
What is Milestone Scientific’s market cap?
Currently, no data Available
When is Milestone Scientific’s upcoming earnings report date?
Milestone Scientific’s upcoming earnings report date is Apr 07, 2025 which is in 106 days.
How were Milestone Scientific’s earnings last quarter?
Milestone Scientific released its earnings results on Nov 14, 2024. The company reported -$0.02 earnings per share for the quarter, missing the consensus estimate of -$0.01 by -$0.01.
Is Milestone Scientific overvalued?
According to Wall Street analysts Milestone Scientific’s price is currently Undervalued.
Does Milestone Scientific pay dividends?
Milestone Scientific does not currently pay dividends.
What is Milestone Scientific’s EPS estimate?
Milestone Scientific’s EPS estimate is -$0.01.
How many shares outstanding does Milestone Scientific have?
Milestone Scientific has 77,892,080 shares outstanding.
What happened to Milestone Scientific’s price movement after its last earnings report?
Milestone Scientific reported an EPS of -$0.02 in its last earnings report, missing expectations of -$0.01. Following the earnings report the stock price went down -4.412%.
Which hedge fund is a major shareholder of Milestone Scientific?
Currently, no hedge funds are holding shares in MLSS
---
Milestone Scientific Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$2.13 (130.27% Upside)
$2.13 (130.27% Upside)
Insider Transactions
Sold Shares
Worth $118.8K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
34.17%
12-Months-Change
Fundamentals
Return on Equity
-63.82%
Trailing 12-Months
Asset Growth
5.59%
Trailing 12-Months
Company Description
Milestone Scientific
Milestone Scientific, Inc. engages in the provision of pioneering proprietary, innovative technological systems and solutions. It also involves in the development, manufacture, market, and selling of computer controlled system for the improved and painless delivery of local anesthetic. It operates through the Dental and Medical segments. The company was founded on August 17, 1989 and is headquartered in Livingston, NJ.
---
MLSS Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a generally positive outlook with significant revenue growth in the third quarter, strong gross margins, and strategic progress in the medical division with Medicare Part B alignment. However, concerns remain with the lack of revenue from China and an overall revenue decline over the nine-month period. Despite these challenges, the company seems well-positioned for future growth, particularly in international markets.Read More>---
MLSS Stock 12 Month Forecast
Average Price Target
$2.13
▲(130.27% Upside)
Technical Analysis
Best Analysts Covering MLSS
1 Year
1 Year Success Rate
8/21 ratings generated profit
1 Year Average Return
-15.14%
reiterated a buy rating last month
Copying Anthony Vendetti's trades and holding each position for 1 Year would result in 38.10% of your transactions generating a profit, with an average return of -15.14% per trade.
---